R&D
Copyright(c)2019 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
PRODUCTS
MANUFACTURING
NEWS
CONTACT US
ABOUT US
Qilu Pharma got CEP for Ondansetron HCl
Classification:
Company news
Author:
Source:
Release time：
2009/12/28 00:00
Page view
[Abstract]:
Recently, we received CEP for Ondansetron HCl from EDQM. It is the second CEP granted to Qilu Pharma this year while the other is for Terbinafine HCl.
EDQM issued the certificate based on the review of our DMF without site inspection. It demonstrate that Qilu has a very strong capability on regulatory affairs and quality management.